Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

Neuropathic pain refers to pain caused by damage or disease to the nervous system.Neuropathic pain differs in pattern from ...

Patent application paves the way for a potential breakthrough in chronic pain treatment, offering renewed hope for ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

Although recent scientific and medical breakthroughs have transformed many people’s lives, there is still quite a bit we do ...

Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...

Several genes are involved in the interindividual variability of the antidepressant response ... implicated in the pathophysiology of chronic pain, but likely also other endogenous substrates.

Approved in March 2019, esketamine is currently indicated for use alongside an oral antidepressant for treatment ... for the current episode, vagal nerve or deep brain stimulation for the current ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

Following its successful debut at the Sundance Film Festival in January, “A Real Pain” is now playing, written and directed by Jesse Eisenberg (who also happens to star in it). He appears alon ...